Effects of celecoxib on voltage-gated calcium channel currents in rat pheochromocytoma (PC12) cells

Pharmacological Research

Volumn 56, Issue 3, 2007, Pages 267-274

  Zhang, Yuan ^a   Tao, Jin ^b   Huang, Hua ^b   Ding, Guoxian ^a   Cheng, Yunlin ^a   Sun, Weihao ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Celecoxib; PC12 cells; Voltage gated calcium channel (VGCC); Whole cell patch clamp

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL N TYPE; CALCIUM CHANNEL R TYPE; CELECOXIB; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; NIFEDIPINE; OMEGA AGATOXIN; OMEGA CONOTOXIN; ROFECOXIB; SNX 482; VOLTAGE GATED CALCIUM CHANNEL;

ANIMAL CELL; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; NONHUMAN; PATCH CLAMP; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; RAT;

ADRENAL GLAND NEOPLASMS; ANIMALS; ANTINEOPLASTIC AGENTS; BARIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CELL PROLIFERATION; CYCLOOXYGENASE 2 INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; ISOQUINOLINES; LACTONES; MEMBRANE POTENTIALS; NIFEDIPINE; NITROBENZENES; OMEGA-AGATOXIN IVA; OMEGA-CONOTOXIN GVIA; PC12 CELLS; PHEOCHROMOCYTOMA; PROTEIN KINASE INHIBITORS; PYRAZOLES; RATS; SPIDER VENOMS; SULFONAMIDES; SULFONES;

EID: 34548260898     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2007.07.004     Document Type: Article

References (29)

1. Vane J.R., Mitchell J.A., Appleton I., Tomlinson A., Bishop-Bailey D., Croxtall J., et al. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc Natl Acad Sci USA 91 6 (1994) 2046-2050
2. Subbaramaiah K., Telang N., Ramonetti J.T., Araki R., DeVito B., Weksler B.B., et al. Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res 56 19 (1996) 4424-4429
3. Sun W.H., Tsuji S., Tsujii M., Gunawan E.S., Kawai N., Kimura A., et al. Induction of cyclooxygenase-2 in rat gastric mucosa by rebamipide, a mucoprotective agent. J Pharmacol Exp Ther 295 2 (2000) 447-452
4. Sun W.H., Sun Y.L., Fang R.N., Shao Y., Xu H.C., Xue Q.P., et al. Expression of cyclooxygenase-2 and matrix metalloproteinase-9 in gastric carcinoma and its correlation with angiogenesis. Jpn J Clin Oncol 35 12 (2005) 707-713
5. DeWitt D.L. COX-2-selective inhibitors: the new super aspirins. Mol Pharmacol 55 4 (1999) 625-631
6. Sheng H., Shao J., Kirkland S.C., Isakson P., Coffey R.J., Morrow J., et al. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest 99 9 (1997) 2254-2259
7. Prescott S.M., and Fitzpatrick F.A. Cyclooxygenase-2 and carcinogenesis. Biochim Biophys Acta 1470 2 (2000) 69-78
8. Grosch S., Tegeder I., Niederberger E., Brautigam L., and Geisslinger G. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib. FASEB J 15 14 (2001) 2742-2744
9. Tegeder I., Niederberger E., Vetter G., Brautigam L., and Geisslinger G. Effects of selective COX-1 and -2 inhibition on formalin-evoked nociceptive behaviour and prostaglandin E(2) release in the spinal cord. J Neurochem 79 4 (2001) 777-786
10. Patel M.I., Subbaramaiah K., Du B., Chang M., Yang P., Newman R.A., et al. Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism. Clin Cancer Res 11 5 (2005) 1999-2007
11. Hsu A.L., Ching T.T., Wang D.S., Song X., Rangnekar V.M., and Chen C.S. The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2. J Biol Chem 275 15 (2000) 11397-11403
12. Alloza I., Baxter A., Chen Q., Matthiesen R., and Vandenbroeck K. Celecoxib inhibits interleukin-12 alphabeta and beta2 folding and secretion by a novel COX2-independent mechanism involving chaperones of the endoplasmic reticulum. Mol Pharmacol 169 (2006) 1579-1587
13. Saini S.S., Gessell-Lee D.L., and Peterson J.W. The cox-2-specific inhibitor celecoxib inhibits adenylyl cyclase. Inflammation 27 (2003) 79-88
14. Kulp S.K., Yang Y.T., Hung C.C., Chen K.F., Lai J.P., Tseng P.H., et al. 3-phosphoinositide-dependent protein kinase-1/Akt signaling represents a major cyclooxygenase-2-independent target for celecoxib in prostate cancer cells. Cancer Res 64 4 (2004) 1444-1451
15. Vivanco I., and Sawyers C.L. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2 7 (2002) 489-501
16. 2+ channels. Annu Rev Cell Dev Biol 16 (2000) 521-555
17. Catterall W.A. Structure and function of voltage-gated ion channels. Annu Rev Biochem 64 (1995) 493-531
18. 2+ channels. Cell Physiol Biochem 9 (1999) 242-269
19. 2+ channel triggers transmitter release in PC12 cells. FEBS Lett 342 (1994) 209-213
20. Day M., Wang Z., Ding J., An X., Ingham C.A., and Shering A.F. Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat Neurosci 9 (2006) 251-259
21. 2+ via L-type voltage-gated calcium channels in rat pheochromocytoma (PC12) cells. Neuropsychopharmacology 31 12 (2006) 2600-2609
22. Tang Z.Z., Liang M.C., Lu S., Yu D., Yu C.Y., Yue D.T., et al. Transcript scanning reveals novel and extensive splice variations in human l-type voltage-gated calcium channel, Cav1.2 alpha1 subunit. J Biol Chem 279 (2004) 44335-44343
23. Tao J., Xu H., Yang C., Liu C.N., and Li S. Effect of urocortin on L-type calcium currents in adult rat ventricular myocytes. Pharmacol Res 50 5 (2004) 471-476
24. Triggle D.J. Calcium-channel antagonists: mechanisms of action, vascular selectivities, and clinical relevance. Cleve Clin J Med 59 6 (1992) 617-627
25. Kunzelmann K. Ion channels and cancer. J Mem Biol 205 3 (2005) 159-173
26. 2+ channel properties in neuroendocrine tumor cell cultures investigated by whole-cell patch-clamp technique. Ann N Y Acad Sci 1014 (2004) 137-139
27. 2+ movement and cell proliferation in human osteoblasts. Biochem Pharmacol 67 6 (2004) 1123-1130
28. Wang G., Lemosm J.R., and Iadecolam C. Herbal alkaloid tetrandrine: fron an ion channel blocker to inhibitor of tumor proliferation. Trends Pharmacol Sci 25 3 (2004) 120-123
29. 2+ fluxes and proliferation in MDCK renal tubular cells. J Recept Signal Transduct Res 25 4-6 (2005) 237-249